Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control

@inproceedings{Stinauer2011StereotacticBR,
  title={Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control},
  author={Michelle A Stinauer and Brian D. Kavanagh and Tracey E. Schefter and Rene C. Gonzalez and Thomas Flaig and Karl D. Lewis and William A. Robinson and Mark Chidel and Michael Glod{\'e} and David Raben},
  booktitle={Radiation oncology},
  year={2011}
}
BACKGROUND Melanoma and renal cell carcinoma (RCC) are traditionally considered less radioresponsive than other histologies. Whereas stereotactic body radiation therapy (SBRT) involves radiation dose intensification via escalation, we hypothesize SBRT might result in similar high local control rates as previously published on metastases of varying histologies. METHODS The records of patients with metastatic melanoma (n = 17 patients, 28 lesions) or RCC (n = 13 patients, 25 lesions) treated… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 2 times over the past 90 days. VIEW TWEETS
49 Citations
38 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 49 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 38 references

Similar Papers

Loading similar papers…